Gossamer Bio, Inc.
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $264.5M | $294.7M | $138.9M |
| Jun 2022 | $262.3M | $245.8M | $94.3M |
| Sep 2022 | $267.2M | $323.5M | $153.5M |
| Dec 2022 | $260.4M | $272.5M | $112.0M |
| Mar 2023 | $248.4M | $219.9M | $65.2M |
| Jun 2023 | $244.5M | $181.7M | $37.0M |
| Sep 2023 | $243.3M | $347.9M | $82.6M |
| Dec 2023 | $249.1M | $311.9M | $32.1M |
| Mar 2024 | $232.6M | $259.4M | $38.9M |
| Jun 2024 | $291.9M | $373.4M | $86.9M |
| Sep 2024 | $296.7M | $350.9M | $28.5M |
| Dec 2024 | $285.8M | $315.3M | $46.1M |
| Mar 2025 | $286.8M | $280.6M | $29.0M |
| Jun 2025 | $287.0M | $240.9M | $26.3M |
| Sep 2025 | $291.2M | $208.8M | $8.9M |
| Dec 2025 | $295.0M | $172.2M | $37.7M |
| Mar 2026 | $290.4M | $128.9M | $41.0M |
| Jun 2026 | $170.9M | $76.9M | $41.1M |